194 related articles for article (PubMed ID: 27450000)
1. Gender biased immune-biomarkers in active tuberculosis and correlation of their profiles to efficacy of therapy.
Chavez K; Ravindran R; Dehnad A; Khan IH
Tuberculosis (Edinb); 2016 Jul; 99():17-24. PubMed ID: 27450000
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects.
You E; Kim MH; Lee WI; Kang SY
Tuberculosis (Edinb); 2016 Jul; 99():100-108. PubMed ID: 27450011
[TBL] [Abstract][Full Text] [Related]
3. Distinct TB-antigen stimulated cytokine profiles as predictive biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis.
Pandiarajan AN; Kumar NP; Selvaraj N; Ahamed SF; Viswanathan V; Thiruvengadam K; Hissar S; Shanmugam S; Bethunaickan R; Nott S; Kornfeld H; Babu S
Front Immunol; 2024; 15():1392256. PubMed ID: 38887283
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigens.
Oliver BG; Elliott JH; Price P; Phillips M; Cooper DA; French MA
J Acquir Immune Defic Syndr; 2012 Nov; 61(3):287-92. PubMed ID: 22732467
[TBL] [Abstract][Full Text] [Related]
5. Relationship between circulating levels of IFN-gamma, IL-10, CXCL9 and CCL2 in pulmonary and extrapulmonary tuberculosis is dependent on disease severity.
Hasan Z; Jamil B; Khan J; Ali R; Khan MA; Nasir N; Yusuf MS; Jamil S; Irfan M; Hussain R
Scand J Immunol; 2009 Mar; 69(3):259-67. PubMed ID: 19281538
[TBL] [Abstract][Full Text] [Related]
6. Development of immune-biomarkers of pulmonary tuberculosis in a rabbit model.
Dehnad A; Ravindran R; Subbian S; Khan IH
Tuberculosis (Edinb); 2016 Dec; 101():1-7. PubMed ID: 27865378
[TBL] [Abstract][Full Text] [Related]
7. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
[TBL] [Abstract][Full Text] [Related]
9. Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study.
Vinhaes CL; Oliveira-de-Souza D; Silveira-Mattos PS; Nogueira B; Shi R; Wei W; Yuan X; Zhang G; Cai Y; Barry CE; Via LE; Fukutani KF; Andrade BB; Mayer-Barber KD
Cytokine; 2019 Nov; 123():154759. PubMed ID: 31226436
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Plasma Cytokine and Chemokine Profiles in Patients with and without Tuberculosis by Liquid Array-Based Multiplexed Immunoassays.
Xiong W; Dong H; Wang J; Zou X; Wen Q; Luo W; Liu S; He J; Cai S; Ma L
PLoS One; 2016; 11(2):e0148885. PubMed ID: 26881918
[TBL] [Abstract][Full Text] [Related]
11. IP-10 and MIG are compartmentalized at the site of disease during pleural and meningeal tuberculosis and are decreased after antituberculosis treatment.
Yang Q; Cai Y; Zhao W; Wu F; Zhang M; Luo K; Zhang Y; Liu H; Zhou B; Kornfeld H; Chen X
Clin Vaccine Immunol; 2014 Dec; 21(12):1635-44. PubMed ID: 25274803
[TBL] [Abstract][Full Text] [Related]
12. CXCL10 is overexpressed in active tuberculosis patients compared to M. tuberculosis-exposed household contacts.
Bhattacharyya C; Majumder PP; Pandit B
Tuberculosis (Edinb); 2018 Mar; 109():8-16. PubMed ID: 29559124
[TBL] [Abstract][Full Text] [Related]
13. Cytokine and chemokine expression profiles in response to Mycobacterium tuberculosis stimulation are altered in HIV-infected compared to HIV-uninfected subjects with active tuberculosis.
Waruk JL; Machuki Z; Mesa C; Juno JA; Anzala O; Sharma M; Ball TB; Oyugi J; Kiazyk S
Tuberculosis (Edinb); 2015 Sep; 95(5):555-61. PubMed ID: 26073895
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium tuberculosis Sonicate-Induced IFNγ, CXCL10 and IL10 can Differentiate Severity in Tuberculosis.
Hasan Z; Rao N; Salahuddin N; Islam M; Ashraf M; Rottenberg ME; Hussain R
Scand J Immunol; 2012 Feb; 75(2):220-6. PubMed ID: 21958213
[TBL] [Abstract][Full Text] [Related]
15. Changes in cytokine responses to TB antigens ESAT-6, CFP-10 and TB 7.7 and inflammatory markers in peripheral blood during therapy.
Leem AY; Song JH; Lee EH; Lee H; Sim B; Kim SY; Chung KS; Kim EY; Jung JY; Park MS; Kim YS; Chang J; Kang YA
Sci Rep; 2018 Jan; 8(1):1159. PubMed ID: 29348638
[TBL] [Abstract][Full Text] [Related]
16. Profiling the human immune response to Mycobacterium tuberculosis by human cytokine array.
Chen T; Li Z; Yu L; Li H; Lin J; Guo H; Wang W; Chen L; Zhang X; Wang Y; Chen Y; Liao Q; Tan Y; Shu Y; Huang W; Cai C; Zhou Z; Yu M; Li G; Zhou L; Zhong Q; Bi L; Zhao M; Guo L; Zhou J
Tuberculosis (Edinb); 2016 Mar; 97():108-17. PubMed ID: 26980502
[TBL] [Abstract][Full Text] [Related]
17. Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis.
Riou C; Perez Peixoto B; Roberts L; Ronacher K; Walzl G; Manca C; Rustomjee R; Mthiyane T; Fallows D; Gray CM; Kaplan G
PLoS One; 2012; 7(5):e36886. PubMed ID: 22606304
[TBL] [Abstract][Full Text] [Related]
18. Immunological host responses as surveillance and prognostic markers in tubercular infections.
Waghmare PJ; Lende T; Goswami K; Gupta A; Gupta A; Gangane N; Kumar S
Int J Mycobacteriol; 2019; 8(2):190-195. PubMed ID: 31210165
[TBL] [Abstract][Full Text] [Related]
19. Exploratory study on plasma immunomodulator and antibody profiles in tuberculosis patients.
Ravindran R; Krishnan VV; Khanum A; Luciw PA; Khan IH
Clin Vaccine Immunol; 2013 Aug; 20(8):1283-90. PubMed ID: 23761664
[TBL] [Abstract][Full Text] [Related]
20. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.
Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC
Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
